Hematology TimesFDA puts drug on fast track to treat secondary AMLJanuary 22, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesEC supports continued use of ponatinibJanuary 21, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesLabel changes report new side effects for hematology drugsJanuary 20, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisPharmacyTransplantation
Hematology TimesNHS cuts 5 blood cancer drugs from CDF, adds 1January 14, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated IssuesCMLNon-Hodgkin Lymphoma
Hematology TimesProduct gets fast track designation for CTCLJanuary 9, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCord blood product gets orphan designationJanuary 8, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersBlood BankingPediatricsPharmacyTransplantation
Hematology TimesCAR T-cell therapy gets orphan designation for DLBCLJanuary 8, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug gets orphan designation for WMJanuary 4, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesNew data added to obinutuzumab labelJanuary 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA approves new formulation of drug for ALLDecember 23, 2014Leukemia, Myelodysplasia, TransplantationPediatricsPharmacy
